Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference
Rhea-AI Summary
Labcorp (NYSE: LH), a leading provider of innovative laboratory services, has announced its participation in the Morgan Stanley 23rd Annual Global Healthcare Conference. The company's executive management team will engage in a fireside chat on Tuesday, September 9, at 7:45 am ET.
Investors and interested parties can access a live audio webcast of the presentation through Labcorp's investor relations website at ir.Labcorp.com. The presentation will also be archived for future replay.
Positive
- None.
Negative
- None.
News Market Reaction – LH
On the day this news was published, LH declined 1.44%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
A live audio webcast of the fireside chat will be available via the Company Investor Relations website at ir.Labcorp.com and archived for replay.
About Labcorp
Labcorp (NYSE: LH) is a global leader of innovative and comprehensive laboratory services that helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities. The company's nearly 70,000 employees serve clients in approximately 100 countries, provided support for more than
View original content to download multimedia:https://www.prnewswire.com/news-releases/labcorp-to-speak-at-the-morgan-stanley-23rd-annual-global-healthcare-conference-302540374.html
SOURCE Labcorp Holdings Inc